Leuven MindGate Visionary seminar 'Human Genome Editing' -14.12.2017

Organised by Leuven MindGate in cooperation with imec and UZ Leuven

Genome editing is a powerful new tool for making precise alterations to an organism’s genetic material. In this way it is possible to edit, add or even delete some of the genetics of plants, animals and humans in a precise, affordable and quick way.
The advances in genome editing can be traced back to quiet beginnings in the 1990s, but the current remarkable surge is largely because of the introduction of the CRISPR-CAS9, a genome-editing tool that can used to make changes in sections of the DNA sequence, in 2012.
Recent scientific advances have spurred an explosion of interest from around the globe in the possible ways in which genome editing can improve human health.

The central question of this visionary seminar isn’t whether or not we will use human genome editing, but in which way and for which applications we will use it.

Practical aspects

Date: Thursday 14 December 2017

imec Auditorium, Kapeldreef 75, 3000 Leuven
Parking is possible near the venue.
[download a route description to the location]


16h00: Welcome coffee
16h30: Welcome by Leuven MindGate and short intro by prof. Wim Robberecht, Chairman of the programme
Prof. KU Leuven, Chairman UZ Leuven
16h45: Mutational mechanisms in human disease and genome editing potential
Eric Legius, Prof. KU Leuven - Center for Human Genetics

CrispR: where are we at, and where are we going?
Adrian Liston, Research Director of Translational Immunology VIB, Prof. KU Leuven

18h00: To CrispR or not to CrispR, biological pros and cons of human genome editing
Hilde Van Esch, Prof., Deputy head of clinic UZ Leuven, Center for Human Genetics
18h30: Coffee break
19h00: Ethical frameworks and social challenges of genome editing
Kris Dierickx, Prof. KU Leuven - Interfacutly Centre for Biomedical Ethics and Law
19h30: Genome editing at Janssen Pharmaceutica: towards disease interception and cure
Pieter Peeters, Senior Director Computational Biology at Janssen Pharmaceutica and
Araz Raoof, Head of External Early Drug Development Europe at Janssen Pharmaceutica
20h00: Q&A
20h20: Networking with drinks and snacks

The interventions will be held in English.

Registration fee

135 euro (excl. VAT): members of Leuven MindGate/ Leuven.Inc - 175 euro (excl. VAT): all others
Special fee available for Master and PhD students affiliated and billable to KU Leuven or other universities.  Please contact us by e-mail.

Participation in our activities at a discount via KMO-portefeuille
Pijler OPLEIDING: Leuven MindGate.  Approval number DV.O219862
More info:


Registrations before 7 December 2017, preferably via the online registration form (use the 'Register' button) or by email to admin@leuvenmindgate.be (including all contact and invoice details).

After registration you will receive a confirmation and route description. The registration fee is payable after receipt of invoice. Cancellation after subscription is not possible. However, replacement by a colleague is allowed.

Concept and content programme © Leuven.Inc

Leuven MindGate groot     imec nieuw logo 10-2016                   UZ Leuven 2




Subscribe to our newsletter

Stay tuned and get our news in your inbox: subscribe here.

Keep me informed
Follow us